Fiche du document
2008
- doi: 10.1155/2008/134059
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1155/2008/134059
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/19125181
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1687-4757[print]
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5F286B16701A1
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Inflammatory processCiter ce document
L. Michalik et al., « PPARs Mediate Lipid Signaling in Inflammation and Cancer. », Serveur académique Lausannois, ID : 10.1155/2008/134059
Métriques
Partage / Export
Résumé
Lipid mediators can trigger physiological responses by activating nuclear hormone receptors, such as the peroxisome proliferator-activated receptors (PPARs). PPARs, in turn, control the expression of networks of genes encoding proteins involved in all aspects of lipid metabolism. In addition, PPARs are tumor growth modifiers, via the regulation of cancer cell apoptosis, proliferation, and differentiation, and through their action on the tumor cell environment, namely, angiogenesis, inflammation, and immune cell functions. Epidemiological studies have established that tumor progression may be exacerbated by chronic inflammation. Here, we describe the production of the lipids that act as activators of PPARs, and we review the roles of these receptors in inflammation and cancer. Finally, we consider emerging strategies for therapeutic intervention.